Radioactive seeds plus standard care may slow spread of cancer

NCT ID NCT07333664

Not yet recruiting Disease control Sponsor: Li Min Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated Jun 12, 2026 · Updated 22 times

Summary

This study is for people with 6 to 10 metastatic tumors (cancer that has spread). It tests whether adding a procedure called iodine-125 seed implantation to standard cancer therapy can better control the disease than standard therapy alone. The seeds deliver targeted radiation directly to tumors. The study will measure how long people live without their cancer getting worse, overall survival, and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The 960th Hospital of People's Liberation Army (PLA)

    Jinan, Shandong, 250031, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.